Covered Self-expandable Metallic Stents Insertion Using Clips and Suture Materials for Preventing Migration

NCT ID: NCT02193789

Last Updated: 2016-02-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-06-30

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In patients of subtotal gastrectomy with Billroth-I or Billroth-II anastomosis, Anastomosis site stricture is very severe complication. It can improve by temporary through the scope covered metallic stent. It is very effective procedure about the stricture. But stent migration is very severe complication. Herein the investigators suggest newly method to prevent the stent migration. Fixation of stent by hemoclip is effective method to prevent stent migration. But it is difficult to remove stent after resolved stricture. So the investigators add the suture between hemoclip and stent. And the investigators cut the suture when stent removal.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastroduodenal Anastomosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Anastomosis site stricture

anastomosis site stricture after subtotal gastrectomy with Billroth-I anastomosis

Group Type EXPERIMENTAL

deployment of through the scope covered metallic stent at the stricture site

Intervention Type PROCEDURE

Deployment of Covered Self-expandable Metallic Stents Insertion fixing with Clips and Suture Material at the stricture site

Covered Self-expandable Metallic Stents

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

deployment of through the scope covered metallic stent at the stricture site

Deployment of Covered Self-expandable Metallic Stents Insertion fixing with Clips and Suture Material at the stricture site

Intervention Type PROCEDURE

Covered Self-expandable Metallic Stents

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* subtotal gastrectomy with Billroth-I or Billroth-II anastomosis
* symptom of gastric outlet obstruction
* anastomosis site stricture after surgery

Exclusion Criteria

* patients of the impossible stent insertion due to other complication
* foreigner
* no agree a concent
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ajou University School of Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kee Myung Lee

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sun Gyo Lim, M.D.

Role: PRINCIPAL_INVESTIGATOR

Ajou University School of Medicine

Ki Seong Lee, M.D.

Role: PRINCIPAL_INVESTIGATOR

Ajou University School of Medicine

Joon Koo Kang, M.D.

Role: PRINCIPAL_INVESTIGATOR

Ajou University School of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ajou university hospital

Suwon, Gyeong-gi Do, South Korea

Site Status

Ajou University Hospital

Suwon, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AJIRB-MED-MDB-14-059

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.